Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis

Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in H...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis Vol. 14; no. 9; pp. 1175 - 1180
Main Authors: Tai, AK, O’Reilly, EJ, Alroy, KA, Simon, KC, Munger, KL, Huber, BT, Ascherio, A
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01-11-2008
Sage Publications
Sage Publications Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1–6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS.
AbstractList Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk ( chi super(2) P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P=0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS.
Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1–6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS.
To assess whether variation in human endogenous retrovirus (HERV)-K18 env , an Epstein-Barr virus (EBV) associated superantigen, is a risk factor for multiple sclerosis (MS), we developed a SNP-based genotyping method to determine the allelic and genotypic distribution of the three alleles of HERV-K18 env. We conducted a nested case-control study amongst 207 MS cases and 403 matched controls drawn from two large ongoing cohorts, the Nurses Health Study and Nurses Health Study 2 (NHS/NHS2). Analyses were replicated in an independent series of 909 MS cases and 339 controls. Overall, in the NHS/NHS2 there was a significant association between HERV K18 env genotype and risk of MS (χ 2 p-value=0.03). As compared with individuals homozygous for the K18.2 allele, risk of MS three fold higher among carriers of two K18.3 alleles (p=0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, homozygous carriers of the K18.3 allele had a significantly increased risk of MS (RR comparing K18.3/K18.3 versus K18.2/K18.2 = 2.7; 95% CI: 1.1 to 6.4). These results suggest that variation in EBV-associated superantigen HERV-K18 env could influence the genetic susceptibility to MS.
BackgroundThe human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS.ObjectiveTo assess whether variation in HERV-K18 Env is a risk factor for MS.MethodsWe developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls.ResultsOverall, there was a significant association between HERV-K18 env genotype and MS risk (chi2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4).ConclusionVariation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS.
Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env . We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. [PUBLICATION ABSTRACT]
Author Alroy, KA
Munger, KL
Tai, AK
Huber, BT
Ascherio, A
O’Reilly, EJ
Simon, KC
AuthorAffiliation 2 Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
1 Department of Pathology, Tufts University School of Medicine, Boston, MA, USA
3 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
4 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA
AuthorAffiliation_xml – name: 3 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
– name: 1 Department of Pathology, Tufts University School of Medicine, Boston, MA, USA
– name: 2 Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
– name: 4 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA
Author_xml – sequence: 1
  givenname: AK
  surname: Tai
  fullname: Tai, AK
  organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA
– sequence: 2
  givenname: EJ
  surname: O’Reilly
  fullname: O’Reilly, EJ
  organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
– sequence: 3
  givenname: KA
  surname: Alroy
  fullname: Alroy, KA
  organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA
– sequence: 4
  givenname: KC
  surname: Simon
  fullname: Simon, KC
  organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
– sequence: 5
  givenname: KL
  surname: Munger
  fullname: Munger, KL
  organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
– sequence: 6
  givenname: BT
  surname: Huber
  fullname: Huber, BT
  organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA
– sequence: 7
  givenname: A
  surname: Ascherio
  fullname: Ascherio, A
  organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA; Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20876759$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18701576$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1rHSEUxaUkNB_tvqsihWY3qTrqdTaFENKkaaCb7MVR59V0Rl915kH_-_p4j6QNlKwUzu8er-ecoIOYokfoHSXnlAJ8oq1gXChBFOm45PQVOqYcoCEdkIN6r3Kz1Y_QSSkPhBCAVrxGR1QBoQLkMbq9WSYTsY8urXxMS8HZzzltQl5K840qfBU32BRscA7lJx6MnVPGIeJpGeewHj0udvQ5lVDeoMPBjMW_3Z-n6P7L1f3lTXP3_frr5cVdY4WSc0OdcEBAsMErbrmVLedAmJNMDM5ax50zru1sx7u-7Qn0nPW9Mr0F1XtJ21P0eWe7XvrJO-vjnM2o1zlMJv_WyQT9rxLDD71KG81AcAqiGpztDXL6tfgy6ykU68fRRF8D0LID2lJQL4K0Ux0HTir44Rn4kJYcawiaUaW4FGwLkR1ka1ol--FxZUr0tk39vM068v7vrz4N7OurwMc9YIo145BNtKE8cowokCC6yjU7rpiVf1ruvw__ARivtg8
CODEN MUSCFZ
CitedBy_id crossref_primary_10_1128_jvi_00356_22
crossref_primary_10_3390_ijms23158330
crossref_primary_10_1371_journal_pone_0053623
crossref_primary_10_1177_1352458511416487
crossref_primary_10_1007_s00415_009_5068_8
crossref_primary_10_1007_s00109_021_02080_4
crossref_primary_10_3109_08830185_2010_485333
crossref_primary_10_1002_cti2_1451
crossref_primary_10_1016_j_jcv_2009_05_015
crossref_primary_10_3109_03009742_2013_779021
crossref_primary_10_3390_ijms21217855
crossref_primary_10_1016_j_envres_2015_11_017
crossref_primary_10_1111_j_1365_2249_2010_04121_x
crossref_primary_10_1111_ane_12775
crossref_primary_10_1016_j_jcv_2009_05_019
crossref_primary_10_3390_ph14010070
crossref_primary_10_1007_s11910_009_0059_9
crossref_primary_10_1007_s11033_016_4004_0
crossref_primary_10_1016_j_jneuroim_2017_02_017
crossref_primary_10_1016_j_it_2009_03_007
crossref_primary_10_1111_j_1365_2249_2010_04132_x
crossref_primary_10_1007_s11910_014_0488_y
crossref_primary_10_1371_journal_pone_0172415
crossref_primary_10_1155_2024_2313062
crossref_primary_10_1017_S2040174411000353
crossref_primary_10_1186_s12985_017_0719_3
crossref_primary_10_1016_j_neurol_2009_07_004
crossref_primary_10_1371_journal_pone_0062090
crossref_primary_10_1016_j_jneuroim_2021_577636
crossref_primary_10_1007_s11481_010_9201_3
crossref_primary_10_3389_fviro_2022_972156
crossref_primary_10_1111_j_1872_034X_2009_00605_x
crossref_primary_10_3390_ijms22115738
crossref_primary_10_3109_08830185_2013_823422
crossref_primary_10_1016_j_bbadis_2010_06_012
crossref_primary_10_3389_fmicb_2020_01690
crossref_primary_10_3390_genes14122150
crossref_primary_10_1007_s10571_014_0100_7
crossref_primary_10_1016_j_jns_2016_11_060
crossref_primary_10_3389_fmicb_2018_00265
crossref_primary_10_3390_genes15060745
crossref_primary_10_1038_nri2527
crossref_primary_10_3390_ijms130911718
crossref_primary_10_1016_j_msard_2021_103318
crossref_primary_10_1189_jlb_0709517
crossref_primary_10_1016_j_bbadis_2010_07_016
crossref_primary_10_1128_JVI_01507_17
crossref_primary_10_3390_v4123701
crossref_primary_10_1186_1743_422X_10_172
Cites_doi 10.1038/ng1885
10.1007/s100720170011
10.1016/S0140-6736(81)91527-0
10.1084/jem.184.3.971
10.1002/ana.21117
10.1212/WNL.53.8.1711
10.3109/13550289609146888
10.1002/ana.20820
10.1001/jama.293.20.2496
10.1016/S1074-7613(01)00212-6
10.1056/NEJMoa073493
10.1128/JVI.69.2.871-881.1995
10.1212/WNL.55.2.164
10.1093/brain/awl067
10.1084/jem.20071030
10.2337/diabetes.53.3.852
10.1016/S0092-8674(00)80338-4
10.1016/S0022-510X(99)00298-1
10.1097/00001648-200003000-00023
10.1136/jnnp.57.8.975
10.1093/oxfordjournals.aje.a009878
10.1038/ni835
10.1056/NEJM200102013440502
10.1128/9781555815844.ch4
ContentType Journal Article
Copyright 2009 INIST-CNRS
SAGE Publications © Nov 2008
Copyright_xml – notice: 2009 INIST-CNRS
– notice: SAGE Publications © Nov 2008
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7TK
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
M0R
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1177/1352458508094641
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Family Health Database (Proquest)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
ProQuest Central Essentials
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Family Health (Alumni Edition)
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts

CrossRef

MEDLINE
Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
EndPage 1180
ExternalDocumentID 1588835541
10_1177_1352458508094641
18701576
20876759
10.1177_1352458508094641
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS047467-04
– fundername: NINDS NIH HHS
  grantid: R01 NS047467
– fundername: PHS HHS
  grantid: R01N504767
GroupedDBID ---
-MK
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
3V.
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADTT
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AAMGE
AANSI
AAPEO
AAQDB
AAQXH
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABJIS
ABJNI
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSBE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEIA
ADMPF
ADNBR
ADRRZ
ADTBJ
ADUCT
ADUKL
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AGKLV
AGNHF
AGWFA
AHHFK
AHMBA
AIGRN
AIOMO
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
ALIPV
ALJHS
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
EJD
EMOBN
ESX
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
HF~
HMCUK
HVGLF
HZ~
J8X
JCYGO
K.F
K.J
K9-
M0R
M1P
M4V
N9A
O9-
P.B
P2P
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAGHA
AAICN
AAMXZ
AANGY
AAPBV
AAWVI
ABJOC
ABNLC
ABPTK
ADGDL
AEMII
AERUW
AGHDM
AGTGN
AIFIH
AUVAJ
BFDSU
H13
IQODW
P.9
ZA5
ACJER
AFVCE
AGWNL
AJXGE
ALKWR
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ADVBO
CITATION
7T5
7TK
7U9
7XB
8FK
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c586t-1d5d70752fe84c4c6344702d625fdccd4ddad39c949b3b07b42bb8abc78be613
IEDL.DBID ARPSY
ISSN 1352-4585
IngestDate Tue Sep 17 21:17:54 EDT 2024
Fri Oct 25 01:17:14 EDT 2024
Fri Oct 25 02:47:33 EDT 2024
Tue Nov 19 07:12:09 EST 2024
Fri Nov 22 02:13:56 EST 2024
Tue Oct 15 23:35:07 EDT 2024
Sun Oct 22 16:04:59 EDT 2023
Tue Jul 16 20:43:19 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords endogenous retroviruses
HLA
polymorphisms
multiple sclerosis
HERV-K18
Human
HLA-System
Nervous system diseases
Multiple sclerosis
Inflammatory disease
Central nervous system disease
Risk factor
Degenerative disease
Polymorphism
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c586t-1d5d70752fe84c4c6344702d625fdccd4ddad39c949b3b07b42bb8abc78be613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc2754175?pdf=render
PMID 18701576
PQID 218846520
PQPubID 38324
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2754175
proquest_miscellaneous_69713178
proquest_miscellaneous_19894740
proquest_journals_218846520
crossref_primary_10_1177_1352458508094641
pubmed_primary_18701576
pascalfrancis_primary_20876759
sage_journals_10_1177_1352458508094641
PublicationCentury 2000
PublicationDate 2008-11-01
PublicationDateYYYYMMDD 2008-11-01
PublicationDate_xml – month: 11
  year: 2008
  text: 2008-11-01
  day: 01
PublicationDecade 2000
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: London
– name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2008
Publisher SAGE Publications
Sage Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications
– name: Sage Publications Ltd
References Rosati G 2001; 22
Conrad B, Weissmahr RN, Böni J, Arcari R, Schüpbach J, Mach B 1997; 90
Hernán MA, Olek MJ, Ascherio A 1999; 53
Warner HB, Carp RI 1981; 2
Levin LI, Munger KL, Rubertone MV 2005; 293
Klaman LD, Thorley-Lawson DA 1995; 69
Rand KH, Houck H, Denslow ND, Heilman KM 2000; 173
Hunter SF, Hafler DA 2000; 55
Lunemann JD, Edwards N, Muraro PA 2006; 129
Ascherio A, Munch M 2000; 11
Sutkowski N, Palkama T, Ciurli C, Sekaly R-P, Thorley-Lawson DA, Huber BT 1996; 184
Sanders VJ, Felisan S, Waddell A, Tourtellotte WW 1996; 2
Ascherio A, Zhang SM, Hernan MA 2001; 344
Ascherio A, Munger KL 2007; 61
Serafini B, Rosicarelli B, Franciotta D 2007; 204
Marguerat S, Wang WY, Todd JA, Conrad B 2004; 53
de Bakker PIW, McVean G, Sabeti PC 2006; 38
Schaid DJ, Jacobsen SJ 1999; 149
Stauffer Y, Marguerat S, Meylan F 2001; 15
The International Multiple Sclerosis Genetics Consortium 2007; 357
Lang HL, Jacobsen H, Ikemizu S 2002; 3
Thacker EL, Mirzaei F, Ascherio A 2006; 59
Hilton DA, Love S, Fletcher A, Pringle JH 1994; 57
9064357 - J Exp Med. 1996 Sep 1;184(3):971-80
14988274 - Diabetes. 2004 Mar;53(3):852-4
11021623 - Epidemiology. 2000 Mar;11(2):220-4
11172163 - N Engl J Med. 2001 Feb 1;344(5):327-32
11603614 - Neurol Sci. 2001 Apr;22(2):117-39
11672541 - Immunity. 2001 Oct;15(4):591-601
17984305 - J Exp Med. 2007 Nov 26;204(12):2899-912
10675577 - J Neurol Sci. 2000 Feb 1;173(1):32-9
12244309 - Nat Immunol. 2002 Oct;3(10):940-3
16569670 - Brain. 2006 Jun;129(Pt 6):1493-506
16502434 - Ann Neurol. 2006 Mar;59(3):499-503
6118702 - Lancet. 1981 Dec 5;2(8258):1290
16998491 - Nat Genet. 2006 Oct;38(10):1166-72
17444504 - Ann Neurol. 2007 Apr;61(4):288-99
9244304 - Cell. 1997 Jul 25;90(2):303-13
10206619 - Am J Epidemiol. 1999 Apr 15;149(8):706-11
7815555 - J Virol. 1995 Feb;69(2):871-81
10563617 - Neurology. 1999 Nov 10;53(8):1711-8
10908883 - Neurology. 2000 Jul 25;55(2):164-5
15914750 - JAMA. 2005 May 25;293(20):2496-500
17660530 - N Engl J Med. 2007 Aug 30;357(9):851-62
atypb9
atypb8
atypb19
atypb15
atypb16
atypb17
atypb18
atypb11
atypb22
atypb12
atypb23
atypb13
atypb24
atypb14
atypb1
atypb3
atypb20
atypb2
atypb10
atypb21
atypb5
atypb4
atypb7
atypb6
References_xml – volume: 357
  start-page: 851
  year: 2007
  end-page: 862
  article-title: Risk alleles for multiple sclerosis identified by a genomewide study
  publication-title: N Engl J Med
  contributor:
    fullname: The International Multiple Sclerosis Genetics Consortium
– volume: 38
  start-page: 1166
  year: 2006
  end-page: 1172
  article-title: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC
  publication-title: Nat Genet
  contributor:
    fullname: Sabeti PC
– volume: 59
  start-page: 499
  year: 2006
  end-page: 503
  article-title: Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis
  publication-title: Ann Neurol
  contributor:
    fullname: Ascherio A
– volume: 57
  start-page: 975
  year: 1994
  end-page: 976
  article-title: Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation
  publication-title: J Neurol Neurosurg Psychiatry
  contributor:
    fullname: Pringle JH
– volume: 204
  start-page: 2899
  year: 2007
  end-page: 2912
  article-title: Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
  publication-title: J Exp Med
  contributor:
    fullname: Franciotta D
– volume: 3
  start-page: 940
  year: 2002
  end-page: 943
  article-title: A functional and structural basis for TCR cross-reactivity in multiple sclerosis
  publication-title: Nat Immunol
  contributor:
    fullname: Ikemizu S
– volume: 69
  start-page: 871
  year: 1995
  end-page: 881
  article-title: Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site
  publication-title: J Virol
  contributor:
    fullname: Thorley-Lawson DA
– volume: 344
  start-page: 327
  year: 2001
  end-page: 332
  article-title: Hepatitis B vaccination and the risk of multiple sclerosis
  publication-title: N Engl J Med
  contributor:
    fullname: Hernan MA
– volume: 22
  start-page: 117
  year: 2001
  end-page: 139
  article-title: The prevalence of multiple sclerosis in the world: an update
  publication-title: Neurol Sci
  contributor:
    fullname: Rosati G
– volume: 2
  start-page: 1290
  year: 1981
  article-title: Multiple sclerosis and Epstein-Barr virus
  publication-title: Lancet
  contributor:
    fullname: Carp RI
– volume: 149
  start-page: 706
  year: 1999
  end-page: 711
  article-title: Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions
  publication-title: Am J Epidemiol
  contributor:
    fullname: Jacobsen SJ
– volume: 173
  start-page: 32
  year: 2000
  end-page: 39
  article-title: Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis
  publication-title: J Neurol Sci
  contributor:
    fullname: Heilman KM
– volume: 184
  start-page: 971
  year: 1996
  end-page: 980
  article-title: An Epstein-Barr virus-associated superantigen
  publication-title: J Exp Med
  contributor:
    fullname: Huber BT
– volume: 53
  start-page: 1711
  year: 1999
  end-page: 1718
  article-title: Geographic variation of MS incidence in two prospective studies of US women
  publication-title: Neurology
  contributor:
    fullname: Ascherio A
– volume: 90
  start-page: 303
  year: 1997
  end-page: 313
  article-title: A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes
  publication-title: Cell
  contributor:
    fullname: Mach B
– volume: 53
  start-page: 852
  year: 2004
  end-page: 854
  article-title: Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes
  publication-title: Diabetes
  contributor:
    fullname: Conrad B
– volume: 2
  start-page: 249
  year: 1996
  end-page: 258
  article-title: Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction
  publication-title: J Neurovirol
  contributor:
    fullname: Tourtellotte WW
– volume: 55
  start-page: 164
  year: 2000
  end-page: 165
  article-title: Ubiquitous pathogens: links between infection and autoimmunity in MS
  publication-title: Neurology
  contributor:
    fullname: Hafler DA
– volume: 15
  start-page: 591
  year: 2001
  end-page: 601
  article-title: Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity
  publication-title: Immunity
  contributor:
    fullname: Meylan F
– volume: 11
  start-page: 220
  year: 2000
  end-page: 224
  article-title: Epstein-Barr virus and multiple sclerosis
  publication-title: Epidemiology
  contributor:
    fullname: Munch M
– volume: 293
  start-page: 2496
  year: 2005
  end-page: 2500
  article-title: Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
  publication-title: JAMA
  contributor:
    fullname: Rubertone MV
– volume: 61
  start-page: 288
  year: 2007
  end-page: 299
  article-title: Environmental risk factors for multiple sclerosis. Part I: the role of infection
  publication-title: Ann Neurol
  contributor:
    fullname: Munger KL
– volume: 129
  start-page: 1493
  year: 2006
  end-page: 1506
  article-title: Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis
  publication-title: Brain
  contributor:
    fullname: Muraro PA
– ident: atypb13
  doi: 10.1038/ng1885
– ident: atypb1
  doi: 10.1007/s100720170011
– ident: atypb3
  doi: 10.1016/S0140-6736(81)91527-0
– ident: atypb21
  doi: 10.1084/jem.184.3.971
– ident: atypb5
  doi: 10.1002/ana.21117
– ident: atypb10
  doi: 10.1212/WNL.53.8.1711
– ident: atypb16
  doi: 10.3109/13550289609146888
– ident: atypb6
  doi: 10.1002/ana.20820
– ident: atypb7
  doi: 10.1001/jama.293.20.2496
– ident: atypb9
  doi: 10.1016/S1074-7613(01)00212-6
– ident: atypb11
  doi: 10.1056/NEJMoa073493
– ident: atypb22
  doi: 10.1128/JVI.69.2.871-881.1995
– ident: atypb2
  doi: 10.1212/WNL.55.2.164
– ident: atypb20
  doi: 10.1093/brain/awl067
– ident: atypb17
  doi: 10.1084/jem.20071030
– ident: atypb23
  doi: 10.2337/diabetes.53.3.852
– ident: atypb8
  doi: 10.1016/S0092-8674(00)80338-4
– ident: atypb18
  doi: 10.1016/S0022-510X(99)00298-1
– ident: atypb4
  doi: 10.1097/00001648-200003000-00023
– ident: atypb15
  doi: 10.1136/jnnp.57.8.975
– ident: atypb14
  doi: 10.1093/oxfordjournals.aje.a009878
– ident: atypb19
  doi: 10.1038/ni835
– ident: atypb12
  doi: 10.1056/NEJM200102013440502
– ident: atypb24
  doi: 10.1128/9781555815844.ch4
SSID ssj0007735
Score 2.1971886
Snippet Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the...
BackgroundThe human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the...
Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the...
To assess whether variation in human endogenous retrovirus (HERV)-K18 env , an Epstein-Barr virus (EBV) associated superantigen, is a risk factor for multiple...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1175
SubjectTerms Biological and medical sciences
Case-Control Studies
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Endogenous Retroviruses - genetics
Epstein-Barr virus
Genetic Predisposition to Disease - epidemiology
Genotype
Human endogenous retrovirus
Humans
Medical sciences
Membrane Proteins - genetics
Membrane Proteins - immunology
Multiple Sclerosis - epidemiology
Multiple Sclerosis - immunology
Multiple Sclerosis - virology
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Polymorphism, Single Nucleotide
Risk Factors
Superantigens - genetics
Superantigens - immunology
Title Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis
URI https://journals.sagepub.com/doi/full/10.1177/1352458508094641
https://www.ncbi.nlm.nih.gov/pubmed/18701576
https://www.proquest.com/docview/218846520
https://search.proquest.com/docview/19894740
https://search.proquest.com/docview/69713178
https://pubmed.ncbi.nlm.nih.gov/PMC2754175
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwEB71ISEkVCivpoXWB4TEwTTOOrFzQhVsVYFaVW0PcIriR8Qe6labTaX--87ksctSQJx6jZ8Zj-3PnvE3AO9EbJV2UnFlveYyHcVce53zSpRJor1XqmXXPzpXJ9_1lzHR5IThLUwvwfojuVVhj9rFmmY33Ubv90bGfYGwQSLQRbiTy0yKT83ssuhuu4egGvSFzNPNJVm2LflD3vLhddsqrBNxHs6I9YOz0_Mf87VbqTYkJ9XPqYGFYfNem0sb2ZPrskaZVl0wjD-h1ftOl794jrWb2eHThxbDM9joYS876PR0E1Z8eA6PjnvD_gv42hoTmA_uqmONZVM_o_LTpubfhGbjcMPKmpWMfOFZFyWITQIbHCJZjfWioCb1S7g4HF98PuJ9mAduU53NuHCpU4hckspraaXNiIQwThyezCpnrZPOlW6U21zmZmRiZWRijC4NKpnxiEZewVq4Cn4LGKKxTMWVyuyokqXROtNGCy_JFonnqDSCD8OQFdcdmUcher7z32UZwe7SmM4LJETihxocwc4wyMUwXAUCJgR0aRJHsDdPxQlLVpgyeBRfQU5qUsl_5MhyJRDW6Qhedyqz6CyurgJPiBGoJWWaZyCy8OWUMPnZkoYnKpUIFSN4Tyq16PHf_n_7fzPuwOPWh6Z9n_kG1mbTxr-F1do1u_3sugOcmzg6
link.rule.ids 230,315,782,786,887,27926,27933,27934,44981,45369
linkProvider SAGE Publications
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwEB1BkQAJsS9hKT4gJA5GSerEzhFBUVmFoAc4RfES0UtATcv3M07SlLIJibMnjj0e22_s8RuAA89VXGjGKVdGUBa0XCqMiGjqJb4vjOG8YNfvPPDbR3HWtjQ5daqvSoP5sQ2rwhYVi3U9u-07cUQMDDEuIp2IhfbJ-gz-IUSDnjm5v3t4qpdhzovsmlae2g_Gd5Rf6pjYkxZekxzVk5Z5Lb4Dnl_jJz8EgRX70vnSP3q0DIsVGCUnpfWswJTJVmH2prpuX4PL4oifmEy_lFyupG8G9gyiP8zplSdIO3sjSU4SYiPUSZm7h_QyMgpTJDnWi33u5evQPW93Tzu0Sr5AVSDCAfV0oDniCT81gimmQksN6Poa_aVUK6WZ1oluRSpikWxJl0vmSykSiUMvDWKEDWhkL5nZAoIYKeRuykPVSlkihQiFFJ5h9oYQvZvAgaOR9uPXkmIj9ioW8s-6caA5MTz1B76l1kO7cmBnNF7xSPMxwhiEWYHvOrBfl-I0sncjSWZQfbENHWOc_SIRRujPe1w4sFmO_rixuOZ56Lc5wCfsohawFN6TJVnvuaDy9nnAEMA5cGitY9zin_q__VfBfZjrdG-u4-uL26sdmC-iXIoXlLvQGPSHZg-mcz1sVpPmHRceECM
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LTxsxEB4VkCIkRFueCxR8QJU4mKw33rX3wCGCRLRpEQIOcFqtHytyWaJswu9nvI-kIW1VqWc_ZI_H9jee8TcAp8zXQhouqNBWUh52fCqtjGnG0iCQ1gpRsutf34ubR3nVczQ5F81fmFqCxbkLq8IRlYe1290jk7VrH2ObIWrgiHMR7cQ8ct_W1ziPJe7Lte7d7f3T7CgWosyw6epT12Dup1zqY-Fe2hilBYooq3Jb_A58LsdQ_hIIVt5N_Y__OatPsFmDUtKttOgzfLD5FrR-1m73bfhePvUTm5uXitOVjO3EvUWMpwUdMEl6-StJC5ISF6lOqhw-ZJiTJlyRFNgvzntY7MBDv_dweU3rJAxUhzKaUGZCIxBXBJmVXHMdOYpAPzBoN2VGa8ONSU0n1jGPVUf5QvFAKZkqVAFlESvswmr-ktt9IIiVIuFnItKdjKdKykgqySx3nkK0ckIPzpoVSEYV1UbCajby97Lx4HhhiWYNAkexh_rlwWGzZkkj_QThDMKtMPA9OJmV4nZyPpI0tyi-xIWQccH_UiOK0a5nQnqwV2nAfLB49jG03zwQC7oxq-CovBdL8uFzSekdiJAjkPPgq9OQ-Yj_NP-Df614Aq3bq37y49vN4BDWy2CX8iPlEaxOxlP7BVYKMz2u980bDPcSoA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+endogenous+retrovirus-K18+Env+as+a+risk+factor+in+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Tai%2C+A+K&rft.au=O%27Reilly%2C+E+J&rft.au=Alroy%2C+KA&rft.au=Simon%2C+K+C&rft.date=2008-11-01&rft.issn=1352-4585&rft.volume=14&rft.issue=9&rft.spage=1175&rft.epage=1180&rft_id=info:doi/10.1177%2F1352458508094641&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-4585&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-4585&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-4585&client=summon